A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect

<table>Survival rates of C-26 tumor cells exposing to the liposomes with or without paclitaxel and Taxol.  The amount of the liposomes corresponding to the paclitaxel liposome was added as the control.</table>

Journal of Drug Delivery

fig3

Figure 3

Figure 3: A Liposomal Formulation Able to Incorporate a High Content of Paclitaxel and Exert Promising Anticancer Effect 